

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | immunoglobulin mediated immune response (GO:0016064) | 7.13997525 |
| 2 | B cell mediated immunity (GO:0019724) | 5.65283789 |
| 3 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 5.35259386 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.18073078 |
| 5 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.17123602 |
| 6 | regulation of antigen processing and presentation (GO:0002577) | 4.85817259 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.84588907 |
| 8 | detection of bacterium (GO:0016045) | 4.76570500 |
| 9 | detection of other organism (GO:0098543) | 4.69463121 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.65579858 |
| 11 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.59851984 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 4.58559186 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 4.58559186 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.58559186 |
| 15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.58559186 |
| 16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.58559186 |
| 17 | modulation by symbiont of host immune response (GO:0052553) | 4.58559186 |
| 18 | positive regulation of antigen processing and presentation (GO:0002579) | 4.55476806 |
| 19 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.49865367 |
| 20 | T-helper 1 type immune response (GO:0042088) | 4.43576430 |
| 21 | neutrophil activation involved in immune response (GO:0002283) | 4.40384052 |
| 22 | positive thymic T cell selection (GO:0045059) | 4.30256648 |
| 23 | response to peptidoglycan (GO:0032494) | 4.22976546 |
| 24 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.22304375 |
| 25 | macrophage activation involved in immune response (GO:0002281) | 4.22297425 |
| 26 | * cellular response to interferon-gamma (GO:0071346) | 4.22265196 |
| 27 | positive regulation of type 2 immune response (GO:0002830) | 4.12543440 |
| 28 | positive regulation of mast cell activation (GO:0033005) | 4.10227652 |
| 29 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.06949812 |
| 30 | positive regulation of mast cell degranulation (GO:0043306) | 4.06432839 |
| 31 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.06432839 |
| 32 | regulation of hypersensitivity (GO:0002883) | 3.97757732 |
| 33 | B cell receptor signaling pathway (GO:0050853) | 3.92957650 |
| 34 | * T cell costimulation (GO:0031295) | 3.92194754 |
| 35 | detection of external biotic stimulus (GO:0098581) | 3.87178973 |
| 36 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.87022264 |
| 37 | * lymphocyte costimulation (GO:0031294) | 3.86439030 |
| 38 | * response to interferon-gamma (GO:0034341) | 3.78570208 |
| 39 | negative regulation of cell killing (GO:0031342) | 3.75224948 |
| 40 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.75224948 |
| 41 | negative regulation of interleukin-12 production (GO:0032695) | 3.70042520 |
| 42 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.65853706 |
| 43 | type I interferon signaling pathway (GO:0060337) | 3.61919557 |
| 44 | cellular response to type I interferon (GO:0071357) | 3.61919557 |
| 45 | response to type I interferon (GO:0034340) | 3.57935913 |
| 46 | regulation of mast cell degranulation (GO:0043304) | 3.56726710 |
| 47 | microglial cell activation (GO:0001774) | 3.53943445 |
| 48 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.50093932 |
| 49 | production of molecular mediator of immune response (GO:0002440) | 3.46890133 |
| 50 | regulation of mast cell activation (GO:0033003) | 3.46066291 |
| 51 | positive regulation of B cell differentiation (GO:0045579) | 3.44222077 |
| 52 | regulation of gamma-delta T cell activation (GO:0046643) | 3.44110992 |
| 53 | defense response to protozoan (GO:0042832) | 3.44007965 |
| 54 | detection of biotic stimulus (GO:0009595) | 3.42118409 |
| 55 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.35482160 |
| 56 | response to host immune response (GO:0052572) | 3.35482160 |
| 57 | myeloid cell activation involved in immune response (GO:0002275) | 3.33647182 |
| 58 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.32875304 |
| 59 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.32167598 |
| 60 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 3.30727368 |
| 61 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.28846806 |
| 62 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.27008937 |
| 63 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.26504612 |
| 64 | positive regulation of interferon-alpha production (GO:0032727) | 3.26370877 |
| 65 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.25723900 |
| 66 | detection of molecule of bacterial origin (GO:0032490) | 3.24000175 |
| 67 | regulation of interferon-alpha production (GO:0032647) | 3.23348929 |
| 68 | myeloid dendritic cell activation (GO:0001773) | 3.22114363 |
| 69 | positive regulation of macrophage cytokine production (GO:0060907) | 3.20155704 |
| 70 | response to protozoan (GO:0001562) | 3.19917729 |
| 71 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.19435934 |
| 72 | regulation of T cell tolerance induction (GO:0002664) | 3.16977465 |
| 73 | positive T cell selection (GO:0043368) | 3.15232761 |
| 74 | negative thymic T cell selection (GO:0045060) | 3.14742993 |
| 75 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.14427551 |
| 76 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.11660389 |
| 77 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.10166250 |
| 78 | T cell migration (GO:0072678) | 3.09444742 |
| 79 | regulation of tolerance induction (GO:0002643) | 3.07188002 |
| 80 | myeloid dendritic cell differentiation (GO:0043011) | 3.04585576 |
| 81 | * antigen receptor-mediated signaling pathway (GO:0050851) | 3.04056428 |
| 82 | positive regulation of leukocyte degranulation (GO:0043302) | 3.03824895 |
| 83 | regulation of B cell differentiation (GO:0045577) | 3.02836288 |
| 84 | response to host (GO:0075136) | 3.01557528 |
| 85 | response to host defenses (GO:0052200) | 3.01557528 |
| 86 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.01557528 |
| 87 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.00470843 |
| 88 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.00417007 |
| 89 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.97559805 |
| 90 | regulation of type 2 immune response (GO:0002828) | 2.97045014 |
| 91 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.95144183 |
| 92 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.94482946 |
| 93 | adaptive immune response (GO:0002250) | 2.92063145 |
| 94 | positive regulation of interferon-gamma production (GO:0032729) | 2.91890871 |
| 95 | germinal center formation (GO:0002467) | 2.90914043 |
| 96 | macrophage activation (GO:0042116) | 2.90874805 |
| 97 | negative T cell selection (GO:0043383) | 2.89677237 |
| 98 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.87896186 |
| 99 | positive regulation of B cell mediated immunity (GO:0002714) | 2.87896186 |
| 100 | response to muramyl dipeptide (GO:0032495) | 2.87428520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.73453726 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.97696716 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.14048926 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.22665255 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.84452838 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.67808165 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.59361856 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.33329785 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.20813495 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.16596193 |
| 11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.04495049 |
| 12 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.93420215 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.80714127 |
| 14 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.66515708 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.63518716 |
| 16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.62224672 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.53480413 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.46387752 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.45789749 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.42626810 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.39951918 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.27835538 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.23029562 |
| 24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.16900234 |
| 25 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.08008284 |
| 26 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.06401686 |
| 27 | SPI1_23127762_ChIP-Seq_K562_Human | 2.05098286 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95748507 |
| 29 | MYC_22102868_ChIP-Seq_BL_Human | 1.95419038 |
| 30 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.93814620 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 1.92682558 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.91419465 |
| 33 | MYB_26560356_Chip-Seq_TH1_Human | 1.90041528 |
| 34 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.88294091 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.86582459 |
| 36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.81347145 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.79373710 |
| 38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.75391895 |
| 39 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.65313660 |
| 40 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.64299105 |
| 41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.60306029 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.60196461 |
| 43 | GATA3_26560356_Chip-Seq_TH2_Human | 1.50437052 |
| 44 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.50148646 |
| 45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.49526472 |
| 46 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48422536 |
| 47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46248854 |
| 48 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43759569 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41304418 |
| 50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41149065 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.33979609 |
| 52 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32686417 |
| 53 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.30715636 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26385266 |
| 55 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.23318820 |
| 56 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21187131 |
| 57 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18793859 |
| 58 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18638646 |
| 59 | MAF_26560356_Chip-Seq_TH2_Human | 1.18261001 |
| 60 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17401164 |
| 61 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16289140 |
| 62 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14272263 |
| 63 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.12954090 |
| 64 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12339704 |
| 65 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10740715 |
| 66 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09273628 |
| 67 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.07760011 |
| 68 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.07065507 |
| 69 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.03504629 |
| 70 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02737632 |
| 71 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.00463773 |
| 72 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00089717 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.99722313 |
| 74 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.98852371 |
| 75 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96291228 |
| 76 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.95968698 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95185332 |
| 78 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.93282425 |
| 79 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91634325 |
| 80 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.88782040 |
| 81 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87878582 |
| 82 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.84552862 |
| 83 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.84541117 |
| 84 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83595972 |
| 85 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.82408953 |
| 86 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79538360 |
| 87 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.78160451 |
| 88 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.77560276 |
| 89 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77180397 |
| 90 | P300_27268052_Chip-Seq_Bcells_Human | 0.76286145 |
| 91 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.75291377 |
| 92 | GATA1_19941826_ChIP-Seq_K562_Human | 0.74969212 |
| 93 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74660340 |
| 94 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.70164795 |
| 95 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.67537251 |
| 96 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.67280610 |
| 97 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.65267280 |
| 98 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.65106089 |
| 99 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.64514088 |
| 100 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.64488147 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.39702643 |
| 2 | MP0005671_abnormal_response_to | 3.85599655 |
| 3 | MP0003303_peritoneal_inflammation | 3.46653996 |
| 4 | MP0005387_immune_system_phenotype | 3.39474338 |
| 5 | MP0001790_abnormal_immune_system | 3.39474338 |
| 6 | MP0001800_abnormal_humoral_immune | 3.35589471 |
| 7 | MP0000685_abnormal_immune_system | 3.31093536 |
| 8 | MP0003724_increased_susceptibility_to | 3.22635277 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 3.15760023 |
| 10 | MP0003436_decreased_susceptibility_to | 3.13770422 |
| 11 | MP0005000_abnormal_immune_tolerance | 3.13535903 |
| 12 | MP0009785_altered_susceptibility_to | 3.11554508 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.93959585 |
| 14 | MP0002419_abnormal_innate_immunity | 2.80990531 |
| 15 | MP0005025_abnormal_response_to | 2.79415361 |
| 16 | MP0002723_abnormal_immune_serum | 2.75670211 |
| 17 | MP0006082_CNS_inflammation | 2.61702975 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.49451941 |
| 19 | MP0001819_abnormal_immune_cell | 2.48742313 |
| 20 | MP0010155_abnormal_intestine_physiology | 2.15604130 |
| 21 | MP0002166_altered_tumor_susceptibility | 2.09769241 |
| 22 | MP0003300_gastrointestinal_ulcer | 1.97939324 |
| 23 | MP0001845_abnormal_inflammatory_respons | 1.91258119 |
| 24 | MP0000716_abnormal_immune_system | 1.90724738 |
| 25 | MP0005464_abnormal_platelet_physiology | 1.85510312 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.84518224 |
| 27 | MP0002398_abnormal_bone_marrow | 1.83833774 |
| 28 | MP0009764_decreased_sensitivity_to | 1.83544702 |
| 29 | MP0005058_abnormal_lysosome_morphology | 1.81169313 |
| 30 | MP0003183_abnormal_peptide_metabolism | 1.76592958 |
| 31 | MP0003075_altered_response_to | 1.76266158 |
| 32 | MP0003763_abnormal_thymus_physiology | 1.73313067 |
| 33 | MP0003172_abnormal_lysosome_physiology | 1.71683297 |
| 34 | MP0002405_respiratory_system_inflammati | 1.71553994 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.60817441 |
| 36 | MP0008469_abnormal_protein_level | 1.60480998 |
| 37 | MP0001533_abnormal_skeleton_physiology | 1.59662347 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.58460682 |
| 39 | MP0004947_skin_inflammation | 1.57608471 |
| 40 | MP0001853_heart_inflammation | 1.57043072 |
| 41 | MP0005166_decreased_susceptibility_to | 1.52562264 |
| 42 | MP0002006_tumorigenesis | 1.52363461 |
| 43 | MP0003806_abnormal_nucleotide_metabolis | 1.50461411 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.50429276 |
| 45 | MP0002429_abnormal_blood_cell | 1.50230390 |
| 46 | MP0000465_gastrointestinal_hemorrhage | 1.36999997 |
| 47 | MP0003866_abnormal_defecation | 1.36922988 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.33600205 |
| 49 | MP0001545_abnormal_hematopoietic_system | 1.33600205 |
| 50 | MP0002722_abnormal_immune_system | 1.33338686 |
| 51 | MP0005310_abnormal_salivary_gland | 1.28399754 |
| 52 | MP0001873_stomach_inflammation | 1.23810159 |
| 53 | MP0000858_altered_metastatic_potential | 1.23307666 |
| 54 | MP0000343_altered_response_to | 1.23174228 |
| 55 | MP0009840_abnormal_foam_cell | 1.22162536 |
| 56 | MP0002139_abnormal_hepatobiliary_system | 1.20504404 |
| 57 | MP0009278_abnormal_bone_marrow | 1.19059848 |
| 58 | MP0002998_abnormal_bone_remodeling | 1.17223948 |
| 59 | MP0005451_abnormal_body_composition | 1.10376221 |
| 60 | MP0002396_abnormal_hematopoietic_system | 1.05932591 |
| 61 | MP0003828_pulmonary_edema | 1.01161153 |
| 62 | MP0003448_altered_tumor_morphology | 0.96066684 |
| 63 | MP0000604_amyloidosis | 0.95604178 |
| 64 | MP0008004_abnormal_stomach_pH | 0.94950151 |
| 65 | MP0009763_increased_sensitivity_to | 0.94780598 |
| 66 | MP0008260_abnormal_autophagy | 0.92943192 |
| 67 | MP0001663_abnormal_digestive_system | 0.88295525 |
| 68 | MP0005165_increased_susceptibility_to | 0.87256076 |
| 69 | MP0000249_abnormal_blood_vessel | 0.86053796 |
| 70 | MP0000703_abnormal_thymus_morphology | 0.85432103 |
| 71 | MP0005075_abnormal_melanosome_morpholog | 0.78805320 |
| 72 | MP0003045_fibrosis | 0.78695068 |
| 73 | MP0005360_urolithiasis | 0.74564353 |
| 74 | MP0004883_abnormal_blood_vessel | 0.73459417 |
| 75 | MP0002132_abnormal_respiratory_system | 0.73443966 |
| 76 | MP0003690_abnormal_glial_cell | 0.71188880 |
| 77 | MP0001851_eye_inflammation | 0.69285655 |
| 78 | MP0002009_preneoplasia | 0.68829170 |
| 79 | MP0002136_abnormal_kidney_physiology | 0.67635932 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 0.67608587 |
| 81 | MP0005164_abnormal_response_to | 0.66684180 |
| 82 | MP0004808_abnormal_hematopoietic_stem | 0.66564338 |
| 83 | MP0004510_myositis | 0.66184082 |
| 84 | MP0009765_abnormal_xenobiotic_induced | 0.63260118 |
| 85 | MP0000490_abnormal_crypts_of | 0.62842916 |
| 86 | MP0003091_abnormal_cell_migration | 0.62581795 |
| 87 | MP0000015_abnormal_ear_pigmentation | 0.62330961 |
| 88 | MP0009643_abnormal_urine_homeostasis | 0.61246297 |
| 89 | MP0000920_abnormal_myelination | 0.61095244 |
| 90 | MP0002933_joint_inflammation | 0.60726654 |
| 91 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.60045857 |
| 92 | MP0005390_skeleton_phenotype | 0.59510262 |
| 93 | MP0000569_abnormal_digit_pigmentation | 0.58897646 |
| 94 | MP0003252_abnormal_bile_duct | 0.56726588 |
| 95 | MP0003795_abnormal_bone_structure | 0.55337979 |
| 96 | MP0002019_abnormal_tumor_incidence | 0.55137567 |
| 97 | MP0000609_abnormal_liver_physiology | 0.54385979 |
| 98 | MP0005319_abnormal_enzyme/_coenzyme | 0.52028180 |
| 99 | MP0000371_diluted_coat_color | 0.51466549 |
| 100 | MP0005535_abnormal_body_temperature | 0.50482801 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 4.87447480 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.64282822 |
| 3 | Meningitis (HP:0001287) | 4.63076668 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.53170196 |
| 5 | Agammaglobulinemia (HP:0004432) | 4.52769938 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.30073045 |
| 7 | Vasculitis (HP:0002633) | 4.23475241 |
| 8 | Mediastinal lymphadenopathy (HP:0100721) | 4.22090794 |
| 9 | Obstructive lung disease (HP:0006536) | 4.07867405 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 4.07867405 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 3.96260292 |
| 12 | Pulmonary infiltrates (HP:0002113) | 3.95595986 |
| 13 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.86288631 |
| 14 | Recurrent cutaneous fungal infections (HP:0011370) | 3.86288631 |
| 15 | Abnormality of the prostate (HP:0008775) | 3.82001199 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.79927740 |
| 17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.69355298 |
| 18 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.66473788 |
| 19 | Recurrent skin infections (HP:0001581) | 3.64565008 |
| 20 | Gastrointestinal stroma tumor (HP:0100723) | 3.63422010 |
| 21 | Myositis (HP:0100614) | 3.62312809 |
| 22 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.57847612 |
| 23 | Panhypogammaglobulinemia (HP:0003139) | 3.57296708 |
| 24 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.55051792 |
| 25 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.55051792 |
| 26 | Abnormality of glycolipid metabolism (HP:0010969) | 3.55051792 |
| 27 | Hemoptysis (HP:0002105) | 3.52793424 |
| 28 | Urticaria (HP:0001025) | 3.51487989 |
| 29 | Recurrent viral infections (HP:0004429) | 3.49763357 |
| 30 | Optic neuritis (HP:0100653) | 3.42076391 |
| 31 | Retrobulbar optic neuritis (HP:0100654) | 3.42076391 |
| 32 | Orchitis (HP:0100796) | 3.39499381 |
| 33 | Chest pain (HP:0100749) | 3.33369050 |
| 34 | Recurrent bronchitis (HP:0002837) | 3.28016297 |
| 35 | Gastrointestinal infarctions (HP:0005244) | 3.28010007 |
| 36 | Colitis (HP:0002583) | 3.22468333 |
| 37 | Recurrent sinusitis (HP:0011108) | 3.13294530 |
| 38 | Cellulitis (HP:0100658) | 3.10697662 |
| 39 | Restrictive lung disease (HP:0002091) | 3.02159953 |
| 40 | Increased cerebral lipofuscin (HP:0011813) | 3.02077841 |
| 41 | Abnormality of the pleura (HP:0002103) | 2.98038856 |
| 42 | Encephalitis (HP:0002383) | 2.95536587 |
| 43 | Chronic diarrhea (HP:0002028) | 2.81315097 |
| 44 | Inflammation of the large intestine (HP:0002037) | 2.78774913 |
| 45 | Gangrene (HP:0100758) | 2.78186008 |
| 46 | Skin rash (HP:0000988) | 2.74824876 |
| 47 | Osteomyelitis (HP:0002754) | 2.74164810 |
| 48 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.70124916 |
| 49 | Stomatitis (HP:0010280) | 2.69951873 |
| 50 | Increased IgM level (HP:0003496) | 2.68035161 |
| 51 | Pulmonary fibrosis (HP:0002206) | 2.65375368 |
| 52 | Vacuolated lymphocytes (HP:0001922) | 2.63817317 |
| 53 | Gastrointestinal inflammation (HP:0004386) | 2.62921318 |
| 54 | Pulmonary embolism (HP:0002204) | 2.56567396 |
| 55 | Xerostomia (HP:0000217) | 2.55253208 |
| 56 | Increased IgE level (HP:0003212) | 2.53303519 |
| 57 | Autoimmune thrombocytopenia (HP:0001973) | 2.52599607 |
| 58 | Recurrent pneumonia (HP:0006532) | 2.51673606 |
| 59 | Spontaneous hematomas (HP:0007420) | 2.51581752 |
| 60 | Amyloidosis (HP:0011034) | 2.50950686 |
| 61 | Lymphopenia (HP:0001888) | 2.49996925 |
| 62 | Keratoconjunctivitis sicca (HP:0001097) | 2.48470152 |
| 63 | Abnormality of T cell number (HP:0011839) | 2.48022966 |
| 64 | Abnormality of B cell number (HP:0010975) | 2.47398760 |
| 65 | IgM deficiency (HP:0002850) | 2.45260440 |
| 66 | Abnormality of T cells (HP:0002843) | 2.42816994 |
| 67 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.42657505 |
| 68 | Loss of speech (HP:0002371) | 2.42423108 |
| 69 | Arterial thrombosis (HP:0004420) | 2.41324322 |
| 70 | Recurrent lower respiratory tract infections (HP:0002783) | 2.39898259 |
| 71 | Abnormality of T cell physiology (HP:0011840) | 2.39893884 |
| 72 | T lymphocytopenia (HP:0005403) | 2.38511259 |
| 73 | Gingivitis (HP:0000230) | 2.36981407 |
| 74 | Chronic otitis media (HP:0000389) | 2.36305195 |
| 75 | Epistaxis (HP:0000421) | 2.34951074 |
| 76 | Hypertensive crisis (HP:0100735) | 2.33272413 |
| 77 | Hypergammaglobulinemia (HP:0010702) | 2.32638363 |
| 78 | Dysostosis multiplex (HP:0000943) | 2.31527005 |
| 79 | Polyneuropathy (HP:0001271) | 2.30185210 |
| 80 | Pustule (HP:0200039) | 2.29860293 |
| 81 | Petechiae (HP:0000967) | 2.29580075 |
| 82 | Keratoconjunctivitis (HP:0001096) | 2.29438891 |
| 83 | Emphysema (HP:0002097) | 2.28562399 |
| 84 | IgG deficiency (HP:0004315) | 2.27625339 |
| 85 | Papilloma (HP:0012740) | 2.27350509 |
| 86 | Verrucae (HP:0200043) | 2.27350509 |
| 87 | Skin ulcer (HP:0200042) | 2.23416354 |
| 88 | Abnormality of male internal genitalia (HP:0000022) | 2.21942230 |
| 89 | B lymphocytopenia (HP:0010976) | 2.20719196 |
| 90 | Glomerulopathy (HP:0100820) | 2.20710470 |
| 91 | Arthralgia (HP:0002829) | 2.20337145 |
| 92 | Leukocytosis (HP:0001974) | 2.19799273 |
| 93 | Acrocyanosis (HP:0001063) | 2.19577334 |
| 94 | Amaurosis fugax (HP:0100576) | 2.19568571 |
| 95 | Premature loss of primary teeth (HP:0006323) | 2.18417596 |
| 96 | Abnormality of the peritoneum (HP:0002585) | 2.16544887 |
| 97 | Glomerulonephritis (HP:0000099) | 2.16439898 |
| 98 | Purpura (HP:0000979) | 2.16257843 |
| 99 | Chronic sinusitis (HP:0011109) | 2.10725051 |
| 100 | Fatigue (HP:0012378) | 2.09660573 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.49559693 |
| 2 | BLK | 4.18827158 |
| 3 | MAP4K1 | 4.06191097 |
| 4 | BMPR2 | 3.42746441 |
| 5 | TYK2 | 3.08634040 |
| 6 | MAP3K14 | 3.02309708 |
| 7 | KIT | 2.81699296 |
| 8 | CSF1R | 2.74773289 |
| 9 | SYK | 2.43093159 |
| 10 | ERN1 | 2.26158489 |
| 11 | JAK3 | 2.24529370 |
| 12 | MAP3K13 | 2.21377292 |
| 13 | TBK1 | 2.09875527 |
| 14 | IRAK4 | 2.08658095 |
| 15 | CDK19 | 2.02457964 |
| 16 | BTK | 1.93415662 |
| 17 | IKBKB | 1.93404214 |
| 18 | PRPF4B | 1.93187950 |
| 19 | IKBKE | 1.91822626 |
| 20 | FES | 1.91581997 |
| 21 | CSK | 1.89195022 |
| 22 | LYN | 1.83332145 |
| 23 | JAK1 | 1.75459642 |
| 24 | TAOK3 | 1.68789087 |
| 25 | MATK | 1.63951588 |
| 26 | TXK | 1.55203479 |
| 27 | ZAP70 | 1.54208946 |
| 28 | TEC | 1.45116938 |
| 29 | SIK3 | 1.37631506 |
| 30 | HCK | 1.36486158 |
| 31 | ITK | 1.29354991 |
| 32 | FGR | 1.23739863 |
| 33 | LCK | 1.20331959 |
| 34 | JAK2 | 1.12262283 |
| 35 | GRK6 | 1.10260224 |
| 36 | GRK7 | 1.07934566 |
| 37 | MAP2K3 | 1.06353663 |
| 38 | TLK1 | 1.01023158 |
| 39 | IRAK3 | 0.95953817 |
| 40 | MAP3K3 | 0.95330582 |
| 41 | TNK2 | 0.93441882 |
| 42 | NME2 | 0.90469966 |
| 43 | CDC42BPA | 0.89553670 |
| 44 | PIK3CG | 0.89050548 |
| 45 | PRKCQ | 0.82007299 |
| 46 | FGFR3 | 0.76264746 |
| 47 | EIF2AK3 | 0.72963430 |
| 48 | PDK1 | 0.72892273 |
| 49 | TRPM7 | 0.71680483 |
| 50 | TAOK2 | 0.71666037 |
| 51 | CHUK | 0.71223058 |
| 52 | MAPK7 | 0.70154436 |
| 53 | KDR | 0.69722217 |
| 54 | MAP3K12 | 0.67661098 |
| 55 | MARK3 | 0.67256289 |
| 56 | ABL1 | 0.63655993 |
| 57 | MAPK12 | 0.61436079 |
| 58 | STK24 | 0.58910882 |
| 59 | MAP3K1 | 0.57252289 |
| 60 | PIM1 | 0.57078806 |
| 61 | FGFR4 | 0.56447914 |
| 62 | IRAK1 | 0.56270817 |
| 63 | STK10 | 0.54844190 |
| 64 | PDPK1 | 0.54118970 |
| 65 | SIK2 | 0.53145758 |
| 66 | SCYL2 | 0.51820586 |
| 67 | TESK2 | 0.50599862 |
| 68 | FYN | 0.50356695 |
| 69 | TGFBR2 | 0.49256371 |
| 70 | CDK6 | 0.47884148 |
| 71 | MAPK11 | 0.47797362 |
| 72 | PRKCD | 0.46262414 |
| 73 | EGFR | 0.46193826 |
| 74 | MST4 | 0.46010927 |
| 75 | NEK9 | 0.45406861 |
| 76 | MAP3K10 | 0.44558764 |
| 77 | MAP3K11 | 0.44361152 |
| 78 | DAPK3 | 0.44127667 |
| 79 | DDR2 | 0.43407469 |
| 80 | RIPK1 | 0.43161898 |
| 81 | SMG1 | 0.41144813 |
| 82 | IGF1R | 0.41093445 |
| 83 | ARAF | 0.40352450 |
| 84 | LRRK2 | 0.39694400 |
| 85 | RPS6KA5 | 0.39500027 |
| 86 | HIPK2 | 0.37881938 |
| 87 | CDK4 | 0.37525923 |
| 88 | YES1 | 0.37224959 |
| 89 | CCNB1 | 0.37138066 |
| 90 | MAPK4 | 0.36958597 |
| 91 | MOS | 0.36456839 |
| 92 | MAPKAPK2 | 0.36185968 |
| 93 | ADRBK2 | 0.34206257 |
| 94 | OXSR1 | 0.33988780 |
| 95 | PIM2 | 0.30274988 |
| 96 | RPS6KL1 | 0.27512196 |
| 97 | RPS6KC1 | 0.27512196 |
| 98 | MAP3K5 | 0.27366109 |
| 99 | DAPK1 | 0.24917597 |
| 100 | INSR | 0.23275699 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Asthma_Homo sapiens_hsa05310 | 5.58963937 |
| 2 | * Allograft rejection_Homo sapiens_hsa05330 | 5.02961200 |
| 3 | * Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.69182925 |
| 4 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 4.64228829 |
| 5 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.33090263 |
| 6 | * Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.96472500 |
| 7 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.71471772 |
| 8 | * Leishmaniasis_Homo sapiens_hsa05140 | 3.17040770 |
| 9 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.02818918 |
| 10 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 2.92933687 |
| 11 | * Viral myocarditis_Homo sapiens_hsa05416 | 2.90054540 |
| 12 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.35392023 |
| 13 | * Tuberculosis_Homo sapiens_hsa05152 | 1.92082752 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.87611350 |
| 15 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.75429718 |
| 16 | * Influenza A_Homo sapiens_hsa05164 | 1.64253580 |
| 17 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.60179123 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.55124012 |
| 19 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.51889882 |
| 20 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.50419660 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.46292944 |
| 22 | * Phagosome_Homo sapiens_hsa04145 | 1.42974800 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.42172614 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.32794596 |
| 25 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.14140064 |
| 26 | Other glycan degradation_Homo sapiens_hsa00511 | 1.09713832 |
| 27 | Pertussis_Homo sapiens_hsa05133 | 1.03277026 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.02243179 |
| 29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.91460342 |
| 30 | Measles_Homo sapiens_hsa05162 | 0.91433579 |
| 31 | Legionellosis_Homo sapiens_hsa05134 | 0.88121049 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.87154474 |
| 33 | Lysosome_Homo sapiens_hsa04142 | 0.86387223 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.78134355 |
| 35 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77704761 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.77382895 |
| 37 | Malaria_Homo sapiens_hsa05144 | 0.76315943 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.74260444 |
| 39 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.71054797 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.68052705 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63672974 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63000320 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 0.62174065 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.61579648 |
| 45 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.58558621 |
| 46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52693674 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 0.51949260 |
| 48 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.49266879 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 0.48828390 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 0.47504507 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.44632545 |
| 52 | Apoptosis_Homo sapiens_hsa04210 | 0.42805259 |
| 53 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41257991 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 0.40017612 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.36704491 |
| 56 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.31946542 |
| 57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.31413769 |
| 58 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.30689966 |
| 59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.23932376 |
| 60 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.21807808 |
| 61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.21362611 |
| 62 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.21121440 |
| 63 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.20525096 |
| 64 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.19044072 |
| 65 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.17390526 |
| 66 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.17336676 |
| 67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.16912005 |
| 68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.12642824 |
| 69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.11182228 |
| 70 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.11166050 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.09854784 |
| 72 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.07442946 |
| 73 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.06816725 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.06344602 |
| 75 | Endocytosis_Homo sapiens_hsa04144 | 0.05780656 |
| 76 | Amoebiasis_Homo sapiens_hsa05146 | 0.05678424 |
| 77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.05573931 |
| 78 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.03513966 |
| 79 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.01462868 |
| 80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.01264792 |
| 81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.01263176 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.00651533 |
| 83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.00408999 |
| 84 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.00140046 |
| 85 | Proteasome_Homo sapiens_hsa03050 | -0.0668040 |
| 86 | Pentose phosphate pathway_Homo sapiens_hsa00030 | -0.0654655 |
| 87 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | -0.0626877 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0559145 |
| 89 | Galactose metabolism_Homo sapiens_hsa00052 | -0.0558645 |
| 90 | Histidine metabolism_Homo sapiens_hsa00340 | -0.0518332 |
| 91 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0516488 |
| 92 | Bladder cancer_Homo sapiens_hsa05219 | -0.0488144 |
| 93 | PPAR signaling pathway_Homo sapiens_hsa03320 | -0.0387910 |
| 94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | -0.0349029 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0317359 |
| 96 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | -0.0203869 |
| 97 | Mineral absorption_Homo sapiens_hsa04978 | -0.0201543 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0089081 |
| 99 | Tryptophan metabolism_Homo sapiens_hsa00380 | -0.0066613 |
| 100 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | -0.0065855 |

